Related Experiment Video

Updated: Mar 15, 2026

A Pediatric Concussion Model in Mice: Closed Head Injury with Long-Term Disorders (CHILD)
07:01

A Pediatric Concussion Model in Mice: Closed Head Injury with Long-Term Disorders (CHILD)

Published on: February 7, 2025

949

Factors related to fatigue after paediatric acquired brain injury (ABI)

F van Markus-Doornbosch1, A J de Kloet1,2, M A M Berger2

  • 1a Sophia Rehabilitation , The Hague , The Netherlands.

Brain Injury
|August 27, 2016
PubMed

Insights

Children and youth experience significant fatigue after brain injuries, particularly non-traumatic brain injuries (NTBI). Older age and single-parent households are linked to increased fatigue levels in pediatric patients.

Area of Science:

  • Pediatric Neurology
  • Rehabilitation Medicine
  • Child Psychology

Background:

  • Acquired brain injury (ABI) in children and youth can lead to persistent symptoms, including fatigue.
  • Understanding the prevalence and contributing factors of fatigue is crucial for effective management and rehabilitation.

Purpose of the Study:

  • To evaluate the extent of fatigue in pediatric patients following traumatic brain injury (TBI) and non-traumatic brain injury (NTBI).
  • To identify factors associated with increased fatigue levels in this population.

Main Methods:

  • A follow-up study involving 88 children and youth (aged 4-20) diagnosed with ABI and their parents.
  • The Paediatric Quality of Life Inventory™ Multidimensional Fatigue Scale (PedsQL™ MFS) was used to assess general, sleep/rest, and cognitive fatigue.
  • Sociodemographic and disease characteristics were also collected.

Main Results:

  • Two to three years post-diagnosis, parent-reported fatigue scores were considerable, especially after NTBI.
  • Child-reported scores showed moderate correlation with parent-reported scores.
  • Factors associated with higher fatigue included older age and single-parent household status.

Conclusions:

  • Fatigue is a significant and persistent issue for children and youth after ABI, with notable levels reported by parents two years post-onset.
  • Interventions should consider age and family structure as potential factors influencing fatigue severity.
Abstract

Keywords:
Health-related quality-of-lifeacquired brain injuryfatiguepaediatricsparticipation

More Related Videos

A Multi-Modal Approach to Assessing Recovery in Youth Athletes Following Concussion10:31

A Multi-Modal Approach to Assessing Recovery in Youth Athletes Following Concussion

Published on: September 25, 2014

14.1K
Assessing Changes in Synaptic Plasticity Using an Awake Closed-Head Injury Model of Mild Traumatic Brain Injury09:49

Assessing Changes in Synaptic Plasticity Using an Awake Closed-Head Injury Model of Mild Traumatic Brain Injury

Published on: January 20, 2023

3.9K

Related Concept Videos

Muscle Recovery and Fatigue01:24

Muscle Recovery and Fatigue

Muscle fatigue refers to the decline in a muscle's ability to maintain the force of contraction after prolonged activity. It primarily stems from changes within muscle fibers. Even before experiencing muscle fatigue, one may feel tired and have the urge to stop the activity. This response, known as central fatigue, occurs due to changes in the central nervous system, namely the brain and spinal cord. While there is no single mechanism that induces fatigue, it may serve as a protective...
4.7K
Fatigue01:21

Fatigue

Fatigue occurs when materials rupture under repeated or fluctuating loads, even at stress levels far below their static breaking strength. It typically results in brittle failure, even for ductile materials. It is a critical consideration in designing machines and structural components subjected to repetitive or varying loads. The nature of these loadings can range from fluctuating loads like unbalanced pump impellers causing vibrations to repeatedly bending a thin steel rod wire back and forth...
975
Acute Respiratory Failure-IV01:23

Acute Respiratory Failure-IV

Respiratory failure can manifest suddenly or gradually, characterized by a rapid decline in PaO2 and a rapid rise in PaCO2. This situation indicates a severe respiratory problem that may quickly become a life-threatening emergency. One of the early signs of hypoxemic Acute Respiratory Failure (ARF) is a change in mental status due to the brain's sensitivity to oxygen levels and changes in acid-base balance. Symptoms such as restlessness, confusion, and agitation suggest inadequate oxygen...
683
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
312
Acute Respiratory Failure-III01:30

Acute Respiratory Failure-III

Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
1.1K
Drug Toxicity: Risk factors01:24

Drug Toxicity: Risk factors

Adverse Drug Reactions (ADRs) are potential complications that arise during pharmacotherapy, influenced by multiple risk factors. Age plays a significant role; both neonates and the elderly are at heightened risk due to their respective immature and diminished metabolic and elimination processes. Gender also impacts ADRs, with females experiencing a 1.5 to 1.7-fold greater risk than males, which may be linked to pharmacokinetic, pharmacodynamic, and hormonal differences. Notably, neonates, the...
93